Giulia Fabbri

Head External ADC Franchise – Translational Medicine – Executive Director – Oncology R&D AstraZeneca

Role
Head External Adc Franchise Translational Medicine Executive Director at AstraZeneca
Location
Boston, MA, US
LinkedIn followers
500 followers

About Giulia Fabbri

Physician‑Scientist and senior Translational Medicine leader with 15+ years in oncology drug development and biomarker strategy. I lead the global translational strategy for partnered ADC assets, unifying mechanistic insights across the portfolio to accelerate development and shape the mechanistic strategy across the AstraZeneca portfolio. I directed Enhertu’s end‑to‑end translational strategy from early development through lifecycle management and have shaped AZ’s ADC vision—advancing the first internal ADC, delivering decision‑enabling biomarker packages, and leading cross‑functional above‑asset initiatives—paired with strong executive influence, KOL/regulatory engagement, and global team building.

Experience

  1. Head External Adc Franchise Translational Medicine Executive Director

    AstraZeneca

    Feb 2026 — Present · Waltham, MA, US

    Define and lead the global translational medicine strategy for partnered ADC assets (Enhertu, Datroway), ensuring alignment between scientific and technological developments and our broader business needs. Unify mechanistic insights across the ADC portfolio to accelerate development and shape our end-to-end mechanistic strategy, advancing our ambition to eliminate cancer as a cause of death.

Education

  • Università degli Studi di Padova

    Doctor of Medicine (M.D.), Medicine - Hematology Oncology

    2005

  • Università degli Studi di Padova

    Licensure and Board Certification, Medicine

    2006

  • Università degli Studi di Padova

    Doctor of Philosophy (Ph.D.), School in Developmental Medicine and Programming Sciences, Immunology and Onco-haematology

    2007 — 2011

Skills

  • Clinical Research
  • Cancer Genomics
  • Research
  • Immunostaining
  • Molecular Biology
  • Computational Biology
  • Protein Expression
  • Pcr
  • Polymerase Chain Reaction (Pcr)
  • Nextgen
  • Real-Time Polymerase Chain Reaction (Qpcr)
  • Immunohistochemistry
  • Chip-Seq
  • Molecular Cloning
  • Science
  • Biochemistry
  • Genetics
  • Mouse Models
  • Cell Signaling
  • Cancer
  • Life Sciences
  • Cell Culture
  • In Vivo
  • Cell Based Assays
  • Molecular & Cellular Biology
  • Translational Medicine
  • Cell Biology
  • Rnaseq
  • Gene Expression Profiling
  • Western Blotting
  • Lncrna
  • In Vitro

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Giulia Fabbri — Head External Adc Franchise Translational Medicine Executive Director at AstraZeneca in Boston, MA, US | Unifers